Department of Therapeutic Research and Medicines Evaluation, Istituto Superiore di Sanità, Viale Regina Elena 299, 00161 Roma, Italy.
Neuropharmacology. 2013 Jan;64:74-80. doi: 10.1016/j.neuropharm.2012.05.031. Epub 2012 May 31.
Rho GTPases are key regulators of the activity-dependent changes of neural circuits. Besides being involved in nervous system development and repair, this neural structural plasticity is believed to constitute the cellular basis of learning and memory. Here we report that concurrent modulation of cerebral Rho GTPases, including Rac, Rho and Cdc42 subfamilies, by Cytotoxic Necrotizing Factor 1 (CNF1, 10 fmol/kg intracerebroventricularly) improves object recognition in both C57BL/6J and CD1 mice. The improvement is long lasting, as it is still observed 90 days post treatment. At this time, the treatment is associated with enhancement of neurotransmission and long-term potentiation. The effects depend on changes in Rho GTPase status, since the recombinant molecule CNF1 C866S, in which the enzymatic activity was abolished through substitution of serine to cysteine at position 866, is ineffective. The study confirms the role of Rho GTPases in learning and suggests that a single administration of CNF1 is effective for a long time after administration. In general, the long-lasting cognition enhancing effect of CNF1 might be beneficial for the treatment of CNS disorders. This article is part of a Special Issue entitled 'Cognitive Enhancers'.
Rho GTPases 是活动依赖性神经回路变化的关键调节因子。除了参与神经系统的发育和修复外,这种神经结构可塑性被认为是学习和记忆的细胞基础。在这里,我们报告说,通过细胞毒性坏死因子 1(CNF1,10 fmol/kg 脑室注射)同时调节大脑 Rho GTPases,包括 Rac、Rho 和 Cdc42 亚家族,可以改善 C57BL/6J 和 CD1 小鼠的物体识别。这种改善是持久的,因为即使在治疗后 90 天仍然可以观察到。此时,治疗与神经传递和长时程增强有关。这些效果取决于 Rho GTPase 状态的变化,因为通过将丝氨酸替换为第 866 位的半胱氨酸而使酶活性丧失的重组分子 CNF1 C866S 是无效的。该研究证实了 Rho GTPases 在学习中的作用,并表明 CNF1 的单次给药在给药后很长一段时间内都是有效的。总的来说,CNF1 的持久认知增强作用可能有益于中枢神经系统疾病的治疗。本文是题为“认知增强剂”的特刊的一部分。